Novartis buying up Alcon - Novartis AG has agreed to buy Nestle AG's 77 percent stake in U.S. company Alcon for $39 billion to boost its eye care business, the Swiss drugmaker said on …
The King of Biz-speak
King Pharmaceuticals has suffered a setback (potential generic competitors for Altace), and will be cutting its employee base significantly. That's the straightforward way to say it. But when …